semaglutide digestive blockage attorney in michigan The FDA has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, patients who took its GLP-1 medications, popularly known as Ozempic and Weight loss drug makers sued
Description
Pharmacological Profile of Once-Weekly Injectable Semaglutide for Chronic Weight Management. Expert Review of Clinical Pharmacology
Salinas et al., 2018)
The active component in Wegovy (semaglutide) has been around for much longer than tirzepatide, so Wegovy has more accumulated long-term evidence, including the SELECT cardiovascular outcome data
The result is an increase in heart rate (tachycardia), elevated blood pressure, and heightened cardiac workload
Blalock-Taussig-Thomas BTT shunt in which the subclavian artery is turned down and anastomosed to the pulmonary artery)
